Abstract:ABSTRACT We have previously shown that ORF45, an immediate-early and tegument protein of Kaposi's sarcoma-associated herpesvirus (KSHV), causes sustained activation of p90 ribosomal S6 kinases (RSKs) and extracellular regulated kinase (ERK) (E. Kuang, Q. Tang, G. G. Maul, and F. Zhu, J Virol 82:1838–1850, 2008, http://dx.doi.org/10.1128/JVI.02119-07). We now have identified the critical region of ORF45 that is involved in RSK interaction and activation. Alanine scanning mutagenesis of this region revealed that a single F66A point mutation abolished binding of ORF45 to RSK or ERK and, consequently, its ability to activate the kinases. We introduced the F66A mutation into BAC16 (a bacterial artificial chromosome clone containing the entire infectious KSHV genome), producing BAC16-45F66A. In parallel, we also repaired the mutation and obtained a revertant, BAC16-45A66F. The reconstitution of these mutants in iSLK cells demonstrated that the ORF45-F66A mutant failed to cause sustained ERK and RSK activation during lytic reactivation, resulting in dramatic differences in the phosphoproteomic profile between the wild-type virus-infected cells and the mutant virus-infected cells. ORF45 mutation or deletion also was accompanied by a noticeable decreased in viral gene expression during lytic reactivation. Consequently, the ORF45-F66A mutant produced significantly fewer infectious progeny virions than the wild type or the revertant. These results suggest a critical role for ORF45-mediated RSK activation in KSHV lytic replication. IMPORTANCE KSHV is the causative agent of three human malignancies. KSHV pathogenesis is intimately linked to its ability to modulate the host cell microenvironment and to facilitate efficient production of progeny viral particles. We previously described the mechanism by which the KSHV lytic protein ORF45 activates the cellular kinases ERK and RSK. We now have mapped the critical region of ORF45 responsible for binding and activation of ERK/RSK to a single residue, F66. We mutated this amino acid of ORF45 (F66A) and introduced the mutation into a newly developed bacterial artificial chromosome containing the KSHV genome (BAC16). This system has provided us with a useful tool to characterize the functions of ORF45-activated RSK upon KSHV lytic reactivation. We show that viral gene expression and virion production are significantly reduced by F66A mutation, indicating a critical role for ORF45-activated RSK during KSHV lytic replication.

Upregulation of ATF4-LAMP3 Axis by ORF45 Facilitates Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Endoplasmic Reticulum-Shaping Atlastin Proteins Facilitate KSHV Replication

ATF4/NUPR1 Axis Promotes Cancer Cell Survival and Mediates Immunosuppression in Clear Cell Renal Cell Carcinoma

Activation and Degradation of Open Reading Frame 45 by the Replication and Transcription Activator of Kaposi's Sarcoma-Associated Herpesvirus.

FoxK1 and FoxK2 cooperate with ORF45 to promote late lytic replication of Kaposi's sarcoma-associated herpesvirus

ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Kaposi's Sarcoma-Associated Herpesvirus RTA Activates the Processivity Factor ORF59 Through Interaction with RBP-Jkappa and a Cis-Acting RTA Responsive Element.

FoxK1 and FoxK2 Cooperate with ORF45 to Promote Late Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus

Activation of P90 Ribosomal S6 Kinase by Orf45 of Kaposi'S Sarcoma-Associated Herpesvirus and Its Role in Viral Lytic Replication

Mechanism of Sustained Activation of Ribosomal S6 Kinase (RSK) and ERK by Kaposi Sarcoma-associated Herpesvirus ORF45: MULTIPROTEIN COMPLEXES RETAIN ACTIVE PHOSPHORYLATED ERK AND RSK AND PROTECT THEM FROM DEPHOSPHORYLATION

Phosphorylation of Eukaryotic Translation Initiation Factor 4B (EIF4B) by Open Reading Frame 45/p90 Ribosomal S6 Kinase (ORF45/RSK) Signaling Axis Facilitates Protein Translation During Kaposi Sarcoma-associated Herpesvirus (KSHV) Lytic Replication*

Activation of P90 Ribosomal S6 Kinases by ORF45 of Kaposi's Sarcoma-Associated Herpesvirus is Critical for Optimal Production of Infectious Viruses.

The Elevated Expression of ORF75, a Lytic KSHV Gene, in Kaposi Sarcoma Lesions is Driven by a GC-rich DNA cis Element in its Promoter Region

The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication.

ORF48 is required for optimal lytic replication of Kaposi’s Sarcoma-Associated Herpesvirus

Modulation of Global SUMOylation by Kaposi's Sarcoma-Associated Herpesvirus and Its Effects on Viral Gene Expression.

Inhibition of AIM2 Inflammasome Activation by SOX/ORF37 Promotes Lytic Replication of Kaposi's Sarcoma- Associated Herpesvirus

ORF45, a Multifunctional Immediate Early and Tegument Protein of KSHV

Kaposi's Sarcoma-Associated Herpesvirus Latent Protein LANA Interacts with HIF-1α to Upregulate RTA Expression During Hypoxia: Latency Control under Low Oxygen Conditions

A Non-Catalytic Herpesviral Protein Reconfigures ERK-RSK Signaling by Targeting Kinase Docking Systems in the Host

Fine-Tuning of the Kaposi’s Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells Through the RTA-JAG1-Notch Pathway